Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06651112
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-11
Brief Title:
The ATP Project Antipsychotic-TEP-Psychosis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impacts of Psychosis and Antipsychotics on Cerebral Energy Metabolism the ATP Project Antipsychotic-TEP-Psychosis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ATP
Brief Summary:
The goal of this observational study is to the early impacts of psychosis and antipsychotic medications on brain metabolism in young adults recently diagnosed with a first episode of psychosis
The main question aims to evaluate the effect of 4 to 6 weeks of antipsychotic medication on brain metabolism measured by PET scan cerebral uptake of 11C-Acetoacetate 18 Fluorodeoxyglucose
Participants will undergo a multimodal imaging protocol with other measures of psychopathology eg cognition depressive symptoms etc and metabolic marker inflammation etc
The main question aims to evaluate the effect of 4 to 6 weeks of antipsychotic medication on brain metabolism measured by PET scan cerebral uptake of 11C-Acetoacetate 18 Fluorodeoxyglucose
Participants will undergo a multimodal imaging protocol with other measures of psychopathology eg cognition depressive symptoms etc and metabolic marker inflammation etc
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None